Article Text

PDF

Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
  1. K Fujiyoshi,
  2. H Suga,
  3. K Okamoto,
  4. S Nakamura,
  5. M Kameyama

    Abstract

    Arginine-vasopressin (AVP) concentrations in five cortical areas were measured post mortem in nine patients with senile dementia of Alzheimer's type (SDAT), and compared with the control group of comparable ages. In SDAT patients, AVP was significantly reduced in Brodmann areas 4, 7 and 10 (p less than 0.05). In areas 17 and 22, the detectability and the mean concentrations of AVP were also lower than those of control patients, although not significantly.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.